MiNK Therapeutics, Inc. (INKT)
NASDAQ: INKT · Real-Time Price · USD
10.10
+0.11 (1.10%)
Feb 21, 2025, 4:00 PM EST - Market closed
MiNK Therapeutics Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Feb '25 Feb 21, 2025 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Market Capitalization | 40 | 37 | 88 | 149 | - | - |
| Market Cap Growth | -21.88% | -58.11% | -40.99% | - | - | - |
| Enterprise Value | 38 | 31 | 64 | 214 | - | - |
| Last Close Price | 10.10 | 10.70 | 26.10 | 44.60 | - | - |
| PB Ratio | -2.28 | -2.05 | -219.74 | 6.28 | - | - |
| P/TBV Ratio | - | - | - | 6.28 | - | - |
| Debt / Equity Ratio | -0.26 | - | - | - | -0.81 | -0.74 |
| Quick Ratio | 0.86 | 0.30 | 1.55 | 2.36 | 0.21 | 0.11 |
| Current Ratio | 0.89 | 0.32 | 1.61 | 2.41 | 0.29 | 0.12 |
| Return on Equity (ROE) | - | - | -239.50% | - | - | - |
| Return on Assets (ROA) | -120.36% | -110.10% | -62.69% | -51.92% | -230.14% | - |
| Return on Capital (ROIC) | - | - | -165.50% | -169.44% | - | - |
| Earnings Yield | -34.43% | -60.80% | -31.74% | -20.22% | - | - |
| FCF Yield | -27.14% | -42.87% | -21.68% | -8.75% | - | - |
| Buyback Yield / Dilution | -6.74% | -2.04% | -29.38% | -7.95% | -0.20% | - |
| Total Shareholder Return | -6.74% | -2.04% | -29.38% | -7.95% | -0.20% | - |
Source: S&P Capital IQ. Standard template.
Financial Sources.